Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.60) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.60) per share from the same period last year.
Glass Lewis Tells Shareholders To Vote Against Elon Musk’s Proposed $56 Billion Compensation Package
Ahead of Tesla Inc's (NASDAQ: TSLA) annual meeting, a major proxy advisory firm recommended that shareholders vote against CEO Elon Musk